Niacin lowers OxPL-apoB in conjunction with Lp(a).
Ezetimibe/simvastatin increases both OxPL–apoB and Lp(a).
A systematic review of trials including OxPL-apoB and Lp(a) measurements showed:
Statin treatment increased OxPL-apoB and Lp(a) levels.
Lipoprotein apheresis and antisense oligonucleotide to apo(a) lower OxPL-apoB and Lp(a).